An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.

An Appropriate Use of Accelerated Approval The FDA decision to grant accelerated approval to aducanumab for Alzheimer’s disease fits squarely in the accelerated approval pathway, which was created ...